Putting Carevive SMART Data to Work

January 1, 2023

Carevive SMART Data is making waves in the pharmaceutical industry as it gets licensed to companies looking to enhance their value chain. This revolutionary dataset is being utilized for crucial use cases, particularly in clinical trials.

Pharmaceutical companies are now leveraging SMART Data to precisely target the right patient populations and determine essential patient experience measures for inclusion in their clinical trials. By integrating this definitive set of Patient-Reported Outcomes (PROs) into new study designs, trials gain a valuable dimension that bolsters the quality of trial data and strengthens regulatory submissions.

We’re excited to discuss Carevive SMART Data with you in-depth, showcasing how it can transform your clinical trials and regulatory strategies. Together, let’s pave the way for more effective and patient-centered therapies in the ever-evolving landscape of cancer care.

Recent Episodes

Medicaid
View episode

The recent unfolding of Medicaid “unwinding” across various states, including Nevada, marks a critical transition in healthcare access for thousands of Americans. With the federal government’s re-evaluation mandates kicking in, numerous individuals find themselves stripped of Medicaid coverage, often for procedural reasons that could have been avoided. This has left a significant gap in […]

third-party
View episode

Recent cyberattacks targeting healthcare organizations have highlighted critical vulnerabilities in their third-party partnerships and underscored the necessity of stringent cyber hygiene practices. As these institutions grapple with the dual challenges of maintaining patient care and protecting sensitive data, the importance of a comprehensive cybersecurity audit becomes ever more apparent. This need to safeguard patient […]

material review
View episode

The material review process in the life sciences sector is undergoing a significant transformation, thanks to the integration of artificial intelligence (AI). This shift comes at a crucial time when the demand for faster, more accurate reviews is at an all-time high, driven by the rapid pace of medical advancements and regulatory complexities. With […]